Key result
Elevated Lp(a) >50 mg/dL is linked to ~38% higher coronary event recurrence in ischemic heart disease.
Why the study?
Are elevated Lp(a) levels associated with greater coronary artery disease burden and difficulty achieving lipid-control targets in patients with ischemic heart disease?
Observational (n=575)
Are elevated Lp(a) levels associated with greater coronary artery disease burden and difficulty achieving lipid-control targets in patients with ischemic heart disease?
Absolute Event Rate: 54.79% vs 39.72%
p-value: p=0.015
No takes yet. Share an insight, caveat, or question.
Elevated Lp(a) serves as a marker for greater coronary atheroma burden, higher event recurrence, and increased difficulty in achieving lipid-control targets in secondary prevention.
Sierra et al. (2026) conducted an observational in ischemic heart disease (n=575). Elevated Lp(a) levels (>50 mg/dL) vs. Lp(a) ≤50 mg/dL was evaluated on recurrence of at least one coronary event (p=0.015). Elevated Lp(a) >50 mg/dL was associated with a higher recurrence of coronary events (54.79% vs. 39.72%, p=0.015) and greater multivessel disease burden in patients with ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: